OPT News: Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights - 30th Aug 2022, 8:00pm

annb0t

Top 20
Opthea Limited

Secured up to US$170m in non-dilutive financing

Received commitments for well supported US$90m equity financing; closed first tranche for US$41.9 million

Expanded management team and US operations with appointment of C-Suite Executives

Elected Mr. Quinton Oswald and Dr. Susan Orr to Board of Directors

MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat high...

>>> Read more: Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights
 
Top Bottom